Literature DB >> 33412552

Femoral Heads from Total Hip Arthroplasty as a Source of Adult Hematopoietic Cells.

Anthony D Pomicter1, Phillip M Clair1, Dongqing Yan1, William L Heaton1, Anna M Eiring1, Michael B Anderson2, Stephen M Richards2, Jeremy Gililland2, Thomas O'Hare1,3, Michael W Deininger4,5.   

Abstract

Normal human bone marrow cells are critical for studies of hematopoiesis and as controls to assess toxicity. As cells from commercial vendors are expensive, many laboratories resort to cancer-free bone marrow specimens obtained during staging or to umbilical cord blood cells, which may be abnormal or reflect a much younger age group compared to the disease samples under study. We piloted the use of femoral heads as an alternative and inexpensive source of normal bone marrow. Femoral heads were obtained from 21 successive patients undergoing elective hip arthroplasty. Mononuclear cells (MNCs) were purified with Ficoll, and CD3+, CD14+, and CD34+ cells were purified with antibody-coated microbeads. The median yield of MNCs was 8.95 × 107 (range, 1.62 × 105-2.52 × 108), and the median yield of CD34+ cells was 1.40 × 106 (range, 3.60 × 105-9.90 × 106). Results of downstream applications including qRT-PCR, colony-forming assays, and ex vivo proliferation analysis were of high quality and comparable to those obtained with standard bone marrow aspirates. We conclude that femoral heads currently discarded as medical waste are a cost-efficient source of bone marrow cells for research use.
© 2021 S. Karger AG, Basel.

Entities:  

Keywords:  Age-matched control; CD34; Hematopoiesis

Mesh:

Substances:

Year:  2021        PMID: 33412552      PMCID: PMC8260615          DOI: 10.1159/000511953

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  12 in total

1.  Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age.

Authors:  Wendy W Pang; Elizabeth A Price; Debashis Sahoo; Isabel Beerman; William J Maloney; Derrick J Rossi; Stanley L Schrier; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

2.  Usability of femoral head bone marrow to verify reference ranges for the assessment of myelodysplasia by flow cytometry.

Authors:  Adriaan J van Gammeren; M van Rijckevorsel; Anne E Bras; Claudia Brandt-Hagens; Jeroen G Te Marvelde; Carin de Visser; Annemiek M C P Joosen; Anton A M Ermens; Vincent H J van der Velden
Journal:  Int J Lab Hematol       Date:  2018-09-02       Impact factor: 2.877

3.  shRNA library screening identifies nucleocytoplasmic transport as a mediator of BCR-ABL1 kinase-independent resistance.

Authors:  Jamshid S Khorashad; Anna M Eiring; Clinton C Mason; Kevin C Gantz; Amber D Bowler; Hannah M Redwine; Fan Yu; Ira L Kraft; Anthony D Pomicter; Kimberly R Reynolds; Anthony J Iovino; Matthew S Zabriskie; William L Heaton; Srinivas K Tantravahi; Michael Kauffman; Sharon Shacham; Alex Chenchik; Kyle Bonneau; Katharine S Ullman; Thomas O'Hare; Michael W Deininger
Journal:  Blood       Date:  2015-01-08       Impact factor: 22.113

4.  Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs.

Authors:  Dana E Rollison; Nadia Howlader; Martyn T Smith; Sara S Strom; William D Merritt; Lynn A Ries; Brenda K Edwards; Alan F List
Journal:  Blood       Date:  2008-04-28       Impact factor: 22.113

5.  Adult, but not neonatal, human lymphoid progenitors respond to TLR9 ligation by producing functional NK-like cells.

Authors:  Eduardo Vadillo; Elisa Dorantes-Acosta; Lourdes Arriaga-Pizano; Antonieta Chavez-Gonzalez; Elba Reyes-Maldonado; Karla P Garrett; Héctor Mayani; Paul W Kincade; Rosana Pelayo
Journal:  Exp Hematol       Date:  2014-04-08       Impact factor: 3.084

6.  Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia.

Authors:  Anna M Eiring; Brent D G Page; Ira L Kraft; Thomas O'Hare; Patrick T Gunning; Michael W Deininger; Clinton C Mason; Nadeem A Vellore; Diana Resetca; Matthew S Zabriskie; Tian Y Zhang; Jamshid S Khorashad; Alexander J Engar; Kimberly R Reynolds; David J Anderson; Anna Senina; Anthony D Pomicter; Carolynn C Arpin; Shazia Ahmad; William L Heaton; Srinivas K Tantravahi; Aleksandra Todic; Richard Moriggl; Derek J Wilson; Riccardo Baron
Journal:  Leukemia       Date:  2014-08-19       Impact factor: 11.528

Review 7.  Inflamm-Aging of Hematopoiesis, Hematopoietic Stem Cells, and the Bone Marrow Microenvironment.

Authors:  Larisa V Kovtonyuk; Kristin Fritsch; Xiaomin Feng; Markus G Manz; Hitoshi Takizawa
Journal:  Front Immunol       Date:  2016-11-14       Impact factor: 7.561

8.  Phenotypic Characterization of Bone Marrow Mononuclear Cells and Derived Stromal Cell Populations from Human Iliac Crest, Vertebral Body and Femoral Head.

Authors:  Marietta Herrmann; Maria Hildebrand; Ursula Menzel; Niamh Fahy; Mauro Alini; Siegmund Lang; Lorin Benneker; Sophie Verrier; Martin J Stoddart; Jennifer J Bara
Journal:  Int J Mol Sci       Date:  2019-07-14       Impact factor: 5.923

9.  Human and Murine Hematopoietic Stem Cell Aging Is Associated with Functional Impairments and Intrinsic Megakaryocytic/Erythroid Bias.

Authors:  Alexandra Rundberg Nilsson; Shamit Soneji; Sofia Adolfsson; David Bryder; Cornelis Jan Pronk
Journal:  PLoS One       Date:  2016-07-01       Impact factor: 3.240

10.  Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashion.

Authors:  William L Heaton; Anna V Senina; Anthony D Pomicter; Mohamed E Salama; Phillip M Clair; Dongqing Yan; Russell N Bell; Jeremy M Gililland; Josef T Prchal; Thomas O'Hare; Michael W Deininger
Journal:  Leukemia       Date:  2018-04-18       Impact factor: 11.528

View more
  1 in total

1.  Trident cold atmospheric plasma blocks three cancer survival pathways to overcome therapy resistance.

Authors:  Bo Guo; Anthony D Pomicter; Francis Li; Sudhir Bhatt; Chen Chen; Wen Li; Miao Qi; Chen Huang; Michael W Deininger; Michael G Kong; Hai-Lan Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-21       Impact factor: 12.779

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.